Literature DB >> 16302994

Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism.

T Kawahara1, I Shimizu, H Ohdan, G Zhao, M Sykes.   

Abstract

Mixed hematopoietic chimerism induced via nonmyeloablative bone marrow transplantation (BMT) leads to unresponsiveness of anti-Gal alpha1,3Gal beta1,4G1cNAc (Gal) natural antibody (NAb)-producing cells in alpha1,3-galactosyltransferase deficient (GalT(-/-)) mice. We analyzed the mechanisms of anti-Gal-producing B cell unresponsiveness induced by Gal(+/+) BMT. C57BL/6 (B6) GalT(-/-) mice received 3Gy whole-body irradiation and BMT from B6-CD45 congenic mice. BMT led to marked reductions in serum anti-Gal IgM levels and in the numbers of splenic anti-Gal-producing cells by 2 weeks post-BMT. B cells with anti-Gal Ig receptors were present in the spleens of 2-week but not 12-week chimeras. In vitro studies and adoptive transfer studies using B6 GalT(-/-)B cell-deficient recipients showed that B cell hyporesponsiveness to Gal at 2 weeks, but not 12 weeks, depended on persistent Gal antigen. Thus, pre-existing B-1 cells are anergic when there is continuous exposure to Gal, whereas long-term unresponsiveness does not require persistent antigen, implicating clonal deletion and/or receptor editing. These results have implications for the potential use of mixed hematopioetic chimerism as an approach to performing organ transplantation in recipients with pre-existing anti-donor IgM antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302994     DOI: 10.1111/j.1600-6143.2005.01121.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

1.  Xenotransplantation as a model of integrated, multidisciplinary research.

Authors:  Emanuele Cozzi; Erika Bosio; Michela Seveso; Domenico Rubello; Ermanno Ancona
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

Review 2.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

3.  B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells.

Authors:  Ichiro Shimizu; Toshiyasu Kawahara; Fabienne Haspot; Philip D Bardwell; Michael C Carroll; Megan Sykes
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

Review 4.  Experimental models of B cell tolerance in transplantation.

Authors:  Michelle L Cowan; Roger Sciammas; Anita S Chong
Journal:  Semin Immunol       Date:  2011-09-16       Impact factor: 11.130

Review 5.  Transplantation tolerance: don't forget about the B cells.

Authors:  A S Chong; S H Khiew
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

Review 6.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 7.  Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.

Authors:  Carrie Gibbons; Megan Sykes
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

8.  High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.

Authors:  Fabienne Haspot; Philip D Bardwell; Guiling Zhao; Megan Sykes
Journal:  Xenotransplantation       Date:  2008 Sep-Oct       Impact factor: 3.907

Review 9.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 10.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.